David P. Meeker
President and CEO at Rhythm Pharmaceuticals; Director at Trevi Therapeutics; Director at Pharvaris. Based in Boston, Massachusetts.
- Rank
- 3486th of 14,644
- Companies held
- 3
- Largest holding
- RYTM, 84.6% of total
- Latest SEC filing
- Sep 14, 2026
- Listed but not counted
- $2.1M
What the $33.0M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Rhythm Pharmaceuticals RYTM Common Stock | Directly | 239,258 | $116.80 | $27.9M | 84.6% | Form 4, Sep 14, 2026 |
| Trevi Therapeutics TRVI Common Stock | Directly | 352,489 | $13.72 | $4.8M | 14.6% | Form 4, Aug 27, 2024 |
| Kardigan KARD Common Stock | Directly | 20,706 | $12.52 | $259K | 0.8% | Form 4, Jun 17, 2026 |
Share counts are the amounts David P. Meeker reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on David P. Meeker's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Pharvaris PHVS Common Stock | Directly Not valued: reported in home-market shares, which trade in the US as depositary shares at a different ratio | 65,167 | $31.66 | $2.1M | — | Form 3, Mar 18, 2026 |
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 3483 | Alison A. Rankin Insider, Hamilton Beach Brands Holding. Mayfield Heights, OH | $33.1M |
| 3484 | Satish Dhanasekaran President and CEO, Keysight Technologies. Santa Rosa, CA | $33.1M |
| 3485 | Jeremy Sg Fowden Director, Primo Brands. Tampa, FL | $33.1M |
| 3486 | David P. Meeker President and CEO, Rhythm Pharmaceuticals. Boston, MA | $33.0M |
| 3487 | Josh D. Paul Chief Accounting Officer, Palo Alto Networks. Santa Clara, CA | $33.0M |
| 3488 | Timothy Go CEO and President, HF Sinclair. Dallas, TX | $33.0M |
| 3489 | Chung-Yao Yin Director, Gogoro | $33.0M |
Other Rhythm Pharmaceuticals insiders
All RYTM insiders- Hunter C. Smith$13.3MChief Financial Officer. #7075 overall
- Yann Mazabraud$6.5MEVP, Head of International. #12037 overall
- Stuart A. Arbuckle$1.4MDirector. #3304 overall
- David W.J. McGirr$1.4MDirector. #6266 overall
- Camille L. Bedrosian$818KDirector. #9587 overall
Questions
How much stock does David P. Meeker own?
David P. Meeker holds $33,040,723 in listed stock based on SEC filings and current prices, mostly Rhythm Pharmaceuticals (RYTM). That ranks 3486th on the Stock Rich List.
Is this David P. Meeker's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did David P. Meeker last buy or sell stock?
The most recent open-market trade on file is a sale of 2,300 RYTM shares on Sep 14, 2026 at $105.19.